Arena Pharmaceuticals, Inc. (ARNA) stock is lower by -23.24% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ARNA stock a score of 32 out of a possible 100. That rank is primarily influenced by a short-term technical score of 1. ARNA's rank also includes a long-term technical score of 35. The fundamental score for ARNA is 60. In addition to the average rating from Wall Street analysts, ARNA stock has a mean target price of $97.43. This means analysts expect the stock to add 52.68% over the next 12 months.
News Home
Is Arena Pharmaceuticals, Inc. (ARNA) Stock a Smart Investment Thursday?
Mentioned in this article
ARNA has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on ARNA!